Aaron Paul Kithcart: When Clinical Research Comes Together at ISTH 2026
Aaron Paul Kithcart, Senior Medical Director in Translational and Clinical Sciences of Hematology at Regeneron, shared a post on LinkedIn:
“Just returned from Paris for ISTH, and the only thing hotter than the conference was the temperature. Seriously!
We shared new data from our FXI and FXII programs, which is always a great opportunity to learn from global leaders in thrombosis. The whole team learned a lot from our interactions, proving once again the value of in person meetings.
We also sat down with investigators for our ongoing and future studies. Nothing replaces a real conversation, clinical research really is a partnership, and I appreciate those who set aside time to talk to us.
And honestly, half the value of ISTH is catching up with colleagues I only see once a year. See you again in Vancouver in 2027!”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 01:43Oliver Weingärtner: Deprescribing of Lipid Lowering Drug after MI is Associated with Cardiovascular Events
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge